Outcome of Patients With Chronic Myeloid Leukemia With Multiple ABL1 Kinase Domain Mutations Receiving Tyrosine Kinase Inhibitor Therapy
Haematologica - Italy
doi 10.3324/haematol.2010.039321
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 28, 2011
Authors
Publisher
Ferrata Storti Foundation (Haematologica)